Delivery Order SPE2DB22D1017-SPE2DB24FF6GC

Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $1,607.48, is for the delivery of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and older. This is a firm fixed-price Delivery Order contract with a completion date of April 30, 2024. The contract does not have a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,480.58 firm fixed-price delivery order is for the COMIRNATY 2024-25 (12Y and up) 0.3mL syringe, a COVID-19 vaccine product, with a completion date of January 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,667.50 firm fixed-price delivery order contract, with a completion date of November 20, 2024, is for the supply of COMIRNATY COVID-19 vaccine syringes for individuals aged 12 and above. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,335.00 firm-fixed-price delivery order is for the supply of COMIRNATY (COVID-19 vaccine) 0.3 mL syringes for recipients aged 12 and above. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $2,009.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of COMIRNATY (COVID-19 vaccine) syringes for individuals 12 years and older, with a period of performance through April 18, 2024. This is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $2,865.95 firm fixed price delivery order is for the supply of COMIRNATY (COVID-19 vaccine) syringes to support military treatment programs and facilities. The order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and up. The $1,480.58 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 31, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,828.88 firm fixed-price delivery order is for the supply of COMIRNATY COVID-19 vaccine vials (0.3 mL) for the 2023-2024 season, with an ultimate completion date of January 19, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY (COVID-19) vaccine syringes for individuals aged 12 and above. The $1,339.98 award has a performance period through March 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. This award is part of a larger indefinite delivery...
This federal contract award, with ID SPE2DB24D2003|SPE2DB25FXEF2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,480.58 delivery order contract is for the supply of COMIRNATY (COVID-19) vaccines for individuals aged 12 and up, with a completion date of January 17, 2025. The contract is a firm fixed-price agreement, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF6GC
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1017|SPE2DB24FF6GC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,339.98 delivery order is for the supply of COMIRNATY 2023-24 (12Y UP) syringe 0.3ML, a COVID-19 vaccine, with an ultimate completion date of April 19, 2024.

Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical and medical products to DLA facilities supporting the DoD worldwide. This delivery order appears to be a call against that larger IDC. No set-aside designation is mentioned for this specific award.

Generated 7/18/24, 9:26 AM